Adbelizumab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
Clinical Study on the Safety and Efficacy of the efficacy and safety of adbelizumab combined
with chemotherapy for neoadjuvant treatment of resectable pancreatic cancer